JESSICA DAVILA to Cholangiocarcinoma
This is a "connection" page, showing publications JESSICA DAVILA has written about Cholangiocarcinoma.
Connection Strength
0.936
-
Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci. 2014 Dec; 59(12):3103-10.
Score: 0.425
-
Cholangiocarcinoma: the "other" liver cancer on the rise. Am J Gastroenterol. 2002 Dec; 97(12):3199-200.
Score: 0.188
-
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011 Aug; 54(2):463-71.
Score: 0.085
-
Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol. 2007 Nov-Dec; 41(10):911-7.
Score: 0.066
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1221-8.
Score: 0.065
-
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005 Mar; 128(3):620-6.
Score: 0.055
-
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar; 40(3):472-7.
Score: 0.051